CFO at Cognition Therapeutics

May 1, 2023
CFO at Cognition Therapeutics

Cognition Therapeutics, Inc., today announced the appointment of John Doyle to the role of Chief Financial Officer. Mr. Doyle has substantial experience leading and managing financial operations at development- and commercial-stage public life sciences companies through financings, mergers, acquisitions and licensing agreements.